Two Sigma Advisers
YARW

Two Sigma Advisers’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Two Sigma Advisers’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,262
Closed -$94.6K – 2129
2025
Q4 		$94.6K Buy
3,262
+2,130
+188% +$42.8K ﹤0.01% 2232
2025
Q3 		$19K Buy
+1,132
New +$37K ﹤0.01% 2303
2021
Q3 		– Sell
-49
Closed -$156K – 2695
2021
Q2 		$156K Sell
49
-205
-81% -$811K ﹤0.01% 2297
2021
Q1 		$1.57M Buy
254
+124
+95% +$899K ﹤0.01% 1395
2020
Q4 		$741K Buy
130
+72
+124% +$452K ﹤0.01% 1707
2020
Q3 		$344K Buy
58
+17
+41% +$99.2K ﹤0.01% 1962
2020
Q2 		$258K Buy
41
+35
+583% +$237K ﹤0.01% 2178
2020
Q1 		$55K Sell
6
-2
-25% -$31.4K ﹤0.01% 2370
2019
Q4 		$138K Sell
8
-1
-11% -$16.7K ﹤0.01% 2233
2019
Q3 		$139K Hold
9
– – ﹤0.01% 2085
2019
Q2 		$183K Buy
9
+1
+13% +$24.7K ﹤0.01% 2147
2019
Q1 		$221K Buy
8
+3
+60% +$72K ﹤0.01% 2091
2018
Q4 		$72K Buy
5
+1
+25% +$22.4K ﹤0.01% 2251
2018
Q3 		$158K Buy
+4
New +$123K ﹤0.01% 2116

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers's YARW Position: Q1 2026 in Review

Two Sigma Advisers sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026, closing a stake of 3,262 shares — an estimated $94.6K sold.

Two Sigma Advisers first reported a position in YARW in Q3 2018 and held it in 14 quarters. The position peaked at $1.57M in Q1 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Two Sigma Advisers reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 3,262 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $94.6K.
  • Two Sigma Advisers first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and held it in 14 quarters.
  • Two Sigma Advisers's Yarrow Bioscience, Inc. Common Stock position peaked at $1.57M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.